miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response
R. Cuttano, T. Colangelo, J. Guarize, E. Dama, M. P. Cocomazzi, F. Mazzarelli, V. Melocchi, O. Palumbo, E. Marino, E. Belloni, F. Montani, M. Vecchi, M. Barberis, P. Graziano, A. Pasquier, , F. Bianchi
The paper identifies a miR-455-5p/PD-L1 axis that drives chemotherapy resistance in lung cancer metastases and predicts neoadjuvant chemotherapy response.
Journal of Hematology & Oncology · Dec 31, 2022Peer-reviewedCancer Biology